<code id='C8FA9D396C'></code><style id='C8FA9D396C'></style>
    • <acronym id='C8FA9D396C'></acronym>
      <center id='C8FA9D396C'><center id='C8FA9D396C'><tfoot id='C8FA9D396C'></tfoot></center><abbr id='C8FA9D396C'><dir id='C8FA9D396C'><tfoot id='C8FA9D396C'></tfoot><noframes id='C8FA9D396C'>

    • <optgroup id='C8FA9D396C'><strike id='C8FA9D396C'><sup id='C8FA9D396C'></sup></strike><code id='C8FA9D396C'></code></optgroup>
        1. <b id='C8FA9D396C'><label id='C8FA9D396C'><select id='C8FA9D396C'><dt id='C8FA9D396C'><span id='C8FA9D396C'></span></dt></select></label></b><u id='C8FA9D396C'></u>
          <i id='C8FA9D396C'><strike id='C8FA9D396C'><tt id='C8FA9D396C'><pre id='C8FA9D396C'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:383
          Nvidia logo -- health tech coverage from STAT
          Adobe

          You didn’t need machine learning to make one prediction about the year’s biggest conference for health care investors, which was held in San Francisco last week. It was going to rain.

          Recursion, a biotechnology firm that uses machine learning for drug development and that was announcing that it is rolling out AI-driven drug discovery software with tech giant Nvidia, decided to seize the moment. As the heavens opened, Recursion employees handed out black umbrellas emblazoned with the Recursion logo and lined with neon images of cells. It was one of a series of publicity grabs from the company, including a satellite event featuring Nvidia’s famous CEO, Jensen Huang, who has become a Wall Street rock star as his company’s stock has exploded due to rising expectations for AI, reaching a $1 trillion market value, the sixth highest in the world.

          advertisement

          Seeing the square outside the Westin St. Francis, where the  J.P. Morgan Healthcare Conference has been held for 42 years, fill with Recursion’s umbrellas was a little like seeing the message that AI was ready for its debut come to life. But it was also true that not everyone was ready to embrace that message.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          In boost for rare disease push, AstraZeneca to buy Amolyt Pharma
          In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

          AlastairGrant/APLONDON— AstraZenecasaidThursdayitwouldpurchasetheFrenchfirmAmolytPharmainadealworthu

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr